Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?

BACKGROUND: The recent outbreak of COVID-19 has raised concerns in the rheumatology community about the management of immunosuppressed patients diagnosed with inflammatory rheumatic diseases. It is not clear whether the use of biological agents may suppose a risk or protection against SARS-CoV-2 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Cristiana Sieiro, Férnandez, Xenia Cásas, Moriano Morales, Clara, Álvarez, Elvira Díez, Álvarez Castro, Carolina, López Robles, Alejandra, Pérez Sandoval, Trinidad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813407/
https://www.ncbi.nlm.nih.gov/pubmed/33455920
http://dx.doi.org/10.1136/rmdopen-2020-001439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813407/
https://www.ncbi.nlm.nih.gov/pubmed/33455920
http://dx.doi.org/10.1136/rmdopen-2020-001439

Ejemplares similares